Experiment shows that optimal PCL/PEG/PVA blends enhance nanocapsule stability and viscosity, suggesting improved drug delivery.
The proper selection of optimal polymeric blends is imperative in the electrospray fabrication of drug-loaded nanocapsules. In this research work, the Central Composite Design-Response Surface Methodology (CCD-RSM) was used to explore the influence of PCL/PEG/PVA polymeric blend ratio and total polymeric concentration on polymeric solution viscosity, long-term stability, and liquid-phase miscibility. The experiment involved the evaluation of three factors: PEG ratio (ranging from 10 wt% to 30 wt%), PVA ratio (ranging from 5 wt% to 15 wt%), and total polymeric concentration (ranging from 3 wt/vol% to 5 wt/vol%), with 20 experiments. The resulting polymeric mixture formula of PCL:PEG: PVA (70:20:10) at a polymeric concentration of 4 wt%/vol exhibited a viscosity index of 72.4±3.1 cP and a long-term stability score of 5/5 (completely transparent). Its absorbance value at 600nm was 0.08 ± 0.01. The proposed quadratic equation, with an R² value of 0.94, demonstrated precise predictability of rheological properties within the experimentally tested process parameters. In general, this research work presents a precise pre-formulation strategy for optimizing electrospray polymeric solutions, facilitating stable processing parameters within normal nanocapsule fabrication processes.
No takes yet. Share an insight, caveat, or question.
Shaghaghian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: